5 h. ago Why security, not growth, is likely to command China’s attention in 2026

China achieved its twin goals of tech advancement and macro stability in 2025. Its goals for 2026 remain the same. However, a rapidly deteriorating global security environment is likely to shift national priorities towards preparation for worst-case scenarios. Oil supplies and sea lanes are becoming insecure. The US-China trade war could reignite at any time. China will have to accelerate its goals of energy and technology self-sufficiency to enhance national resilience. Fighting for sea lane...

Events

1 week ago China signals: BYD’s ascent, beauty’s foreign retreat, and the next engines of growth

China signals: BYD’s ascent, beauty’s foreign retreat, and the next engines of growth  Jing Daily

Politics

1 week ago China furious after US captures Maduro, condemns America as global power shift accelerates

China furious after US captures Maduro, condemns America as global power shift accelerates  Fox Business

Politics

1 week ago Nvidia CEO Jensen Huang credits DeepSeek with accelerating open

Nvidia CEO Jensen Huang on Monday credited Chinese start-up DeepSeek with “activating” a global shift towards open-source artificial intelligence, as he used a keynote at the Consumer Electronics Show (CES) in Las Vegas to unveil new hardware aimed at training ever more powerful AI systems. Speaking at the annual trade show, Huang said DeepSeek’s models – released earlier last year – had accelerated the growth of the open-source ecosystem, even after the company’s R1 model, which required fewer...

Politics

2 w. ago The ‘biology winter’ thaws: why investors are piling into Hong Kong’s biotech IPOs

Hong Kong’s biotech fundraising momentum is expect to extend into 2026, as licensing deals and strong post-initial public offering (IPO) trading last year persuaded investors that China’s drug developers are worth backing again – even before they generate revenue. “Chinese innovation drugs expanding into overseas markets have become the industry mainstream, indicating the domestic innovation sector has entered its harvest phase,” said Felix Huang, head of equity at Oakwise Capital. “New trends...

Economics

2 w. ago China’s biopharma sector ‘in prime position to challenge US leadership’

China’s biopharmaceutical sector is said to have entered an “innovation 2.0” phase as it moves to a commercialisation mindset that could see it sideline global competitors and outpace the US – despite restrictive trade policies. In recent years, innovative drug development in the world’s second-largest pharmaceutical market has rapidly approached – and in some cases surpassed – that of the United States, the world’s biggest market. Growing concerns over China’s biotech capabilities have led the...

Politics

2 w. ago A Global Shift: China Is About to Become the World’s Top Car Seller

A Global Shift: China Is About to Become the World’s Top Car Seller  Autoblog

Politics

3 w. ago From Private Jets to Budget Seats: How China’s Offshore Aviation Shift Is Reshaping Travel Routes for Global Tourists

From Private Jets to Budget Seats: How China’s Offshore Aviation Shift Is Reshaping Travel Routes for Global Tourists  Travel And Tour World

Economics

3 w. ago Trump’s pivot puts Pacific Rim at heart of global power shift

While US-China relations are likely to warm in 2026 and US President Donald Trump’s National Security Strategy strikes a comparatively softer tone, the long-term trajectory of the two nations’ rivalry remains irreversible. Strategic competition will only intensify, focusing ever more on economic and security issues in the Pacific Rim. Notably, the Pentagon’s call for a major US military overhaul centred on the Pacific Rim could raise the risk of security confrontation. This dynamic will further...

Politics

3 w. ago Opinion | Trump’s pivot puts Pacific Rim at heart of global power shift

Opinion | Trump’s pivot puts Pacific Rim at heart of global power shift  South China Morning Post

Politics

3 w. ago Genomic sequencing puts Hong Kong at forefront of cancer care innovation

Genomic sequencing has helped Hong Kong identify the right treatments for cancer patients more quickly, according to an expert who also suggested that the city could be a “super-linker” between mainland China and the rest of the world in drug development. Aya El Helali, a clinician-scientist in medical oncology at the University of Hong Kong, praised how collaboration within the Greater Bay Area had opened up opportunities to run clinical trials faster and at lower costs – factors that appealed...

Politics

3 w. ago China’s biopharma ascent signals shift in global drug development leadership

China’s biopharma ascent signals shift in global drug development leadership  The Pharma Letter

Politics

last month Hong Kong and Singapore landlords embrace flex offices as multinationals reshape demand

Landlords in Hong Kong and Singapore are expected to continue allocating space to flexible office operators as multinational corporations reshape the sector’s risk profile and fuel long-term demand, according to industry experts. A major driver behind this shift is the rapid change in who uses flexible workspaces. Global companies now represented 41 per cent of Asia-Pacific flex office users, the highest proportion worldwide and nearly triple North America’s 14 per cent, according to Piers...

Politics